(412) 586-4678

Online Shop

Back to Products


Additional images:

CBD Pain Balm 1000mg/Jar (Unscented)


A smooth and spreadable (unscented) balm applied topically to painful areas like arthritic joints and painful damaged nerve areas. Massage in well as often as needed. Heat the area for a few minutes first for enhanced absorption. 

Broad Spectrum PCR – Phytocannabinoid Rich Plant Oil with CBD and other minor phytocannabinoids such as cannabigerol – CBG, cannabinol – CBN, and cannabichromene – CBC, and over 40 naturally present synergistic terpenes.

  • No Detectable THC
  • No Detectable Solvents
  • No Detectable Pesticides
  • No Detectable Heavy Metals
  • Products are tested both internally and independently for potency, purity, and consistency.

Links to Certificates of Analysis:
Green Scientific - Certificate of Analysis 
Folium Biosciences Certificate of Quality Assurance and Internal Analysis
CannaSafe - Aliquot

Organically Farmed in accordance with Industrial Regulations (Reg. #69763)

Hydrogenated Water and Supercritical CO2 Extraction Process – CO2 extraction allows the operator to tune the extraction using the process parameters (pressure, temperature, time, etc.) to extract specific compounds most efficiently. Ethanol extraction is less specific and will result in a lot of terpenes, waxes, and chlorophyll with your target compound. 

Help us further CBD Research! Filling out our questionnaire will help us collect important data about CBD and your experience. Click here to fill out our CBD Questionnaire. Please call (412) 586-4678 or (412) 421-4996 if you would like further guidance.

Consult your healthcare provider before use if pregnant.

For more information on CBD please consult the following paper from the National Institutes of Health: PACHER P, BÁTKAI S, KUNOS G. The Endocannabinoid System as an Emerging Target of Pharmacotherapy. Pharmacological reviews. 2006;58(3):389-462. doi:10.1124/pr.58.3.2.

And the World Health Organization’s paper, “CANNABIDIOL (CBD) Pre-Review Report Agenda Item 5.2 Expert Committee on Drug Dependence, Thirty-ninth Meeting, Geneva, 6-10 November 2017.